The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair

被引:117
|
作者
Lee, SH
Oshige, M
Durant, ST
Rasila, KK
Williamson, EA
Ramsey, H
Kwan, L
Nickoloff, JA
Hromas, R
机构
[1] Univ New Mexico, Hlth Sci Ctr, Div Hematol Oncol, Canc Res & Treatment Ctr,Dept Med, Albuquerque, NM 87131 USA
[2] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[3] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
关键词
DNA repair; histone methylation;
D O I
10.1073/pnas.0503676102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The molecular mechanism by which foreign DNA integrates into the human genome is poorly understood yet critical to many disease processes, including retroviral infection and carcinogenesis, and to gene therapy. We hypothesized that the mechanism of genomic integration may be similar to transposition in lower organisms. We identified a protein, termed Metnase, that has a SET domain and a transposase/nuclease domain. Metnase methylates histone H3 lysines 4 and 36, which are associated with open chromatin. Metnase increases resistance to ionizing radiation and increases nonhomologous end-joining repair of DNA double-strand breaks. Most significantly, Metnase promotes integration of exogenous DNA into the genomes of host cells. Therefore, Metnase is a nonhomologous end-joining repair protein that regulates genomic integration of exogenous DNA and establishes a relationship among histone modification, DNA repair, and integration. The data suggest a model wherein Metnase promotes integration of exogenous DNA by opening chromatin and facilitating joining of DNA ends. This study demonstrates that eukaryotic transposase domains can have important cell functions beyond transposition of genetic elements.
引用
收藏
页码:18075 / 18080
页数:6
相关论文
共 50 条
  • [31] A KRAS-NRF2-53BP1 Nonhomologous End-Joining Repair Pathway Mediates Oncogenic KRAS Radioresistance
    Williams, T. M.
    Yang, L.
    Estrada-Bernal, A.
    Chatterjee, M.
    Robb, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S31 - S31
  • [32] Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
    Broustas, Constantinos G.
    Duval, Axel J.
    Chaudhary, Kunal R.
    Friedman, Richard A.
    Virk, Renu K.
    Lieberman, Howard B.
    ONCOGENE, 2020, 39 (12) : 2467 - 2477
  • [33] Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
    Constantinos G. Broustas
    Axel J. Duval
    Kunal R. Chaudhary
    Richard A. Friedman
    Renu K. Virk
    Howard B. Lieberman
    Oncogene, 2020, 39 : 2467 - 2477
  • [34] Non-homologous end-joining proteins are required for Agrobacterium T-DNA integration
    van Attikum, H
    Bundock, P
    Hooykaas, PJJ
    EMBO JOURNAL, 2001, 20 (22): : 6550 - 6558
  • [35] Ku DNA End-Binding Activity Promotes Repair Fidelity and Influences End-Processing During Nonhomologous End-Joining in Saccharomyces cerevisiae
    Emerson, Charlene H.
    Lopez, Christopher R.
    Ribes-Zamora, Albert
    Polleys, Erica J.
    Williams, Christopher L.
    Yeo, Lythou
    Zaneveld, Jacques E.
    Chen, Rui
    Bertuch, Alison A.
    GENETICS, 2018, 209 (01) : 115 - 128
  • [36] The roles of the human SETMAR (Metnase) protein in illegitimate DNA recombination and non-homologous end joining repair
    Tellier, Michael
    Chalmers, Ronald
    DNA REPAIR, 2019, 80 : 26 - 35
  • [37] Linking double-stranded DNA breaks to the recombination activating gene complex directs repair to the nonhomologous end-joining pathway
    Cui, Xiaoping
    Meek, Katheryn
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) : 17046 - 17051
  • [38] Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway
    Wang, Qinhong
    Gao, Fengqin
    May, W. Stratford
    Zhang, Yangde
    Zhang, Tammy
    Deng, Xingming
    MOLECULAR CELL, 2008, 29 (04) : 488 - 498
  • [39] DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
    Gkotzamanidou, Maria
    Terpos, Evangelos
    Bamia, Christina
    Munshi, Nikhil C.
    Dimopoulos, Meletios A.
    Souliotis, Vassilis L.
    BLOOD, 2016, 128 (09) : 1214 - 1225
  • [40] Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage
    Adachi, N
    Iiizumi, S
    So, S
    Koyama, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (04) : 856 - 861